Microsoft Word[removed]NOV Tysabri webcast.doc

First Page		Document Content
Immunology Natalizumab Multiple sclerosis Progressive multifocal leukoencephalopathy Biogen Idec Food and Drug Administration JC virus Immunosuppressants Health Medicine		Microsoft Word[removed]NOV Tysabri webcast.doc Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 128,48 KB Share Document on Facebook

	Trustee Lynn Schenk Lynn Schenk is an attorney and consultant in private practice with extensive public policy and business experience. She serves on the Board of Directors for Sempra Energy, Biogen Idec, the Scripps Re DocID: 1tNv2 - View Document
	Tufts CSDD 2015 Leadership for Drug Development Teams Sponsor Rate Eligibility List: Amgen Inc. Bayer Healthcare Pharmaceuticals Biogen Idec, Inc. Biotechnology (BIO) DocID: 1eCyL - View Document
	Special Article Reprint • July 14, 2014 A CenterWatch Publication Biogen Idec turns to MyHealthTeam in successful test of social networks for enrolling MS clinical trial DocID: 1d2zh - View Document
	Tufts CSDD 2015 Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation Sponsor Rate Eligibility List: Amgen Inc. Bayer Healthcare Pharmaceuticals Biogen Idec, Inc. Biotechnology (BIO) DocID: 1cLP6 - View Document
	Bedrijf Abbvie Actelion Alcon ALK Abello Allergan DocID: 1aFBs - View Document